Background--Congenital heart disease is the most common type of birth defect, affecting %2% of the population. Malformations involving the cardiac outflow tract and semilunar valves account for >50% of these cases predominantly because of a bicuspid aortic valve, which has an estimated prevalence of 1% in the population. We previously reported that mutations in NOTCH1 were a cause of bicuspid aortic valve in nonsyndromic autosomal-dominant human pedigrees. Subsequently, we described a highly penetrant mouse model of aortic valve disease, consisting of a bicuspid aortic valve with thickened cusps and associated stenosis and regurgitation, in Notch1-haploinsufficient adult mice backcrossed into a Nos3-null background.
B
icuspid aortic valve (BAV) is the most common congenital anomaly, with an estimated incidence of 1.3% in the population. 1 Along with BAV, developmental anomalies of the semilunar valves and cardiac outflow tract (OFT) account for a significant proportion of congenital heart defects and result in a substantial clinical burden for affected patients. [2] [3] [4] Multiple cell lineages are responsible for the development of the cardiac OFT and semilunar valves. 5 During early heart development, cells from the anterior second heart field (SHF) contribute to formation of the cardiac OFT, also known as the conotruncus. [6] [7] [8] In addition, a subpopulation of endothelial cells that line the OFT undergo endothelial-tomesenchymal transition to form the OFT cushions. These mesenchymal cells are joined by the migrating cardiac neural crest cells, which are required for septation of the aorta and pulmonary artery. [9] [10] [11] Proper migration and signaling of all 3 cell lineages, the SHF, cardiac neural crest and endothelialderived mesenchymal cells are required for normal OFT cushion development and semilunar valve remodeling. The Notch signaling pathway has been shown to be important for multiple aspects of heart development, from endocardial cushion formation to myocardial development, and mutations in this pathway have been linked to a spectrum of congenital heart defects in humans. 12 The Notch family is composed of 4 receptors responsible for various cell-fate decisions and for vascular development and disease. 12, 13 These receptors are transmembrane signaling proteins that contain a ligand-binding extracellular domain and an intracellular domain. On binding with its ligand, a series of cleavage events release the Notch intracellular domain, which translocates to the nucleus and binds with its cofactors mastermind-like protein and RBPJj to regulate expression of target genes. 14 Specifically, the Notch signaling family has been shown to play a critical role in cardiac OFT development because loss of the Notch signaling pathway, specifically in the SHF via a dominant-negative truncated form of mastermind-like protein or loss of Jagged1, results in a spectrum of OFT defects including aortic valve abnormalities. 15 Furthermore, mutations in NOTCH2 and the Notch ligand JAGGED1 are responsible for Alagille syndrome, which is characterized by pulmonary stenosis, ventricular septal defects, coarctation of the aorta, and tetralogy of Fallot, among other developmental defects. 16, 17 
Tissue Fixation and Histology
Embryos were harvested at the indicated time points and fixed in 10% formalin at 4°C overnight. Sections (6 lm) were stained with hematoxylin and eosin and imaged at 950. Valve area was determined by the average area across 3 sections of each leaflet using AxioVision software (Zeiss). Cell density was determined by dividing the number of nuclei in each valve leaflet by the measured area. Valve excavation, as described by Dupuis et al, 25 was determined by the ratio of space across the valve by sections en face and calculated by ImageJ (National Institutes of Health). A minimum of 3 sections of each valve were performed.
Immunofluorescence was performed using anti-green fluorescent protein (ab290, 1:1000; Abcam) and anti-PECAM1 (sc-1506, 1:50; Santa Cruz Biotechnology) and was counterstained with Vector Laboratories Hardset Mounting Medium with DAPI (H-1500).
Statistics
Statistical analysis was performed on quantitative graphs using the Mann-Whitney test because of the small number of mice used and the lack of normality, with median and 25th and 75th percentiles reported. For categorical data, the Fisher exact test was used. P<0.05 was considered significant.
Results
Neonatal Lethality in Notch1
To determine the embryonic phenotype of Notch1 +/À ;Nos3
mice, we bred Notch1 +/À ;Nos3 +/À and Nos3 À/À mice and examined the resultant litters at postnatal day 10. We found %65% lethality in Notch1 +/À ;Nos3 À/À pups at postnatal day 10, whereas no lethality was observed in littermate controls ( Figure 1A ). Interestingly, this was contrasted by expected Mendelian ratios for all genotypes between embryonic day (E) 11.5 and E18.5 ( Figure 1A ). Examination of Notch1 +/À ;Nos3 Although the valve leaflets of compound mutant animals were larger, they contained fewer nuclei per unit area ( Figure 3I , 3J, and 3L). Remodeling of the aortic valve cushions occurs during the later stages of gestation; therefore, examination of Notch1 +/À ;Nos3 À/À embryos at E15.5 was performed. Compound mutant hearts demonstrated thickened valve leaflets ( Figure 3H ) compared with control animals ( Figure 3E through 3G) and were accompanied by a reduction in aortic valve excavation ( Figure 3M ). 25 These results suggest that Notch1 signaling is required for normal development of the cardiac OFT and for proper remodeling of the semilunar valves. Figure 4E . Notch1 fl/wt ;Tie2-Cre +/À ;Nos3 À/À mice displayed thickened aortic ( Figure 4C ) and pulmonary valves ( Figure 4D ) compared with littermate controls ( Figure 4A and 4B), and the aortic valves were also found to have reduced cell density ( Figure 4F ) similar to that of Notch1
À/À mice ( Figure 3L ). To determine whether Notch1 was required in other cell lineages, we used the SHF-specific driver Mef2C-Cre. 22 Notch1 fl/wt ;Mef2C-Cre +/À ;Nos3 À/À animals also displayed thickened aortic and pulmonary leaflets compared with littermate controls, although to a lesser extent than the Notch1 fl/wt ;Tie2-Cre +/À ;Nos3 À/À animals ( Figure 5A through 5F). SHF lineage tracing with ROSA26 mT/mG24 mice showed that a subset of endothelial cells within the aorta and aortic valves were derived from the SHF ( Figure 5G and 5H). SHFderived endothelial cells are also known to populate the pulmonary trunk and pulmonary valve, suggesting that the effect of Notch1 may still be limited to the endothelial cell layer. 22 Because other publications have implicated the role of neural crest cells in OFT formation, we obtained neural crestspecific Wnt1-Cre mice to ascertain the role of Notch1 specifically in the neural crest. 23 We did not observe any cardiac phenotypes in Notch1 fl/wt ;Wnt1-Cre +/À ;Nos3
mice. This finding suggests that Notch1 in the neural crest is not responsible for the cardiovascular and semilunar valve phenotypes observed in the Notch1 +/À ;Nos3 À/À mice (Figure 6 ). Although our results do not preclude the possibility of SHF cells requiring Notch1, they demonstrate a critical role of Notch1 within the endothelial cells for the proper development of the semilunar valves and cardiac OFT.
Discussion
We have described the cardiac phenotype in Notch1-haploinsufficient embryos backcrossed into a Nos3-null background. Our studies demonstrate that although adult survivors display isolated aortic valve anomalies, mutant embryos have a spectrum of cardiac phenotypes including thickened semilunar valve leaflets, overriding aorta, and ventricular septal defects. In addition, we found that loss of Notch1 in endothelial and endothelial-derived cells resulted in a spectrum of cardiac OFT defects and semilunar valve anomalies in our model. In summary, these findings highlight the importance of endothelial Notch1 in multiple aspects of cardiac OFT development including semilunar valve remodeling. Notch1 is a transmembrane signaling receptor responsible for many developmental processes.
14 The Notch signaling family proteins are expressed in multiple cardiac lineages and during different stages of development and have the ability to act in a noncell autonomous fashion, resulting in signal transduction to multiple cell types. 12, 15 Our results indicate that Notch1 is required within the endothelial cell lineage for proper OFT development and semilunar valve remodeling; however, the cell lineages with which Notch1 communicates have not been well defined. Similar to Notch1, deletion of Gata5 or Alk2 in the OFT endothelial (endocardial) and endothelial-derived mesenchymal cells is sufficient to cause BAV. [27] [28] [29] In addition, the cardiac neural crest is critical for the development of the cardiac OFT because loss of BMP signaling via the receptor ALK2 has been shown to cause persistent truncus arteriosus, improper cardiac neural crest migration causes OFT defects, and the loss of Rho kinase signaling within neural crest cells gives rise to BAV. [30] [31] [32] We did not observe any cardiac malformations using a neural crest-specific Cre driver to delete Notch1; however, this does not exclude the possibility that Notch1 in endothelial-derived cells may be signaling to neural crest cells in the cardiac OFT. Neural crest cells have been shown to direct mesenchymal cell fate decisions within the developing cardiac OFT, and it is possible that Notch1 in endothelial and endothelial-derived cells has the capacity to act in a similar role via the neural crest. 33 Our data also leaflets, so named for their spatial arrangement to the coronary arteries. BAVs may result from the fusion of any leaflet, although in humans, right-left fusion is most common. 34 The process of leaflet fusion is currently not well understood because leaflet fusion may occur early in cushion development or later during valve remodeling. Gata5 knockout mice display BAV, which is caused by an early fusion without leaflet thickening, unlike that of ALK2 mutant mice, which demonstrate thickened valve leaflets at early stages. 27, 30 Some studies have concluded that BAV subtypes are a result of specific genetic etiologies because Gata5 À/À mice and Nos3 À/À mice display BAVs with right-noncoronary fusion. 27, 35 Further research using genetic sequencing in humans has also suggested this because human BAV patients harboring rare GATA5 mutations have a higher incidence of right-left and right-noncoronary BAVs. 36 Nevertheless, a study of 1849 inbred Syrian hamsters with a high probability of homozygosity found variable aortic valve morphology and suggested that environmental factors, rather than genetics, account for BAV morphology. 37, 38 Gene-environment interactions may also play a role in the development of BAV because mutations in the Notch signaling pathway combined with environmental effectors have been demonstrated to increase the penetrance of disease states. 39 Accordingly, we examined the BAV morphology in the Notch1 +/À ;Nos31 À/À adult mice and identified a variable morphology, with leftright, right-noncoronary, and left-noncoronary fusion all observed (n=4, data not shown). In summary, our work demonstrates the role for Notch1 in OFT and semilunar valve development. Interestingly, examination of the families reported in the original publication linking NOTCH1 mutations and congenital heart defects demonstrates the presence of an individual with tetralogy of Fallot, a phenotype consistent with the phenotype observed in the Notch1 +/À ;Nos3 À/À embryos. 18 This potential link was further supported by the identification of a microdeletion encompassing NOTCH1 in a patient with tetralogy of Fallot by chromosomal microarray. 18, 40 Further recent evidence supporting a link between NOTCH1 mutations and right-sided congenital heart defect is the identification of mutations in NOTCH1 in 2 additional families with malformations of rightsided cardiac structures. 41, 42 Further investigation is required to determine whether mutations in NOTCH1 are found in children with malformations affecting both the right (pulmonary) and left (aortic) sides of the developing OFT.
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